ACTIVE

Labotoxico

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

-28,2 k €

+84.5% YoY

Gross margin

134,2 k €

+243.2% YoY

Equity

2,5 M €

-1.1% YoY

Workforce

0,0 ETP

What does Labotoxico do?

Labotoxico is a Public limited company incorporated in 1987. Its registered office is in Damme.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0432.685.722

Incorporation

20/11/1987

Legal form

Public limited company

Registered office

Dorpsstraat 110
8340 Damme · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

30/06/2025

Average workforce

0,0 ETP

Joint committees (4)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	134,2 k €	+243%	39,1 k €	-38.4%	63,5 k €	-36.8%	100,5 k €	-0.9%	101,3 k €	-84.5%	654,2 k €	+407%	129 k €	-86.1%	925,2 k €	+540%	144,7 k €	-0.3%	145,1 k €	+19.6%	121,3 k €	-3.8%	126,1 k €	-62.5%	336,1 k €	-59.5%	830,5 k €	+3.4%	802,9 k €	+6.6%	753,3 k €	-1.7%	766,3 k €	-23.4%	999,9 k €
EBITDA	120,8 k €	+462%	-33,4 k €	-155%	60,5 k €	-36.5%	95,4 k €	+13.4%	84,1 k €	-86.6%	629,9 k €	+592%	91,1 k €	-89.8%	893 k €	+662%	117,2 k €	+25.8%	93,1 k €	+28.6%	72,4 k €	-40.5%	121,8 k €	-17.3%	147,3 k €	-60.1%	369,1 k €	+21.0%	305 k €	-12.4%	348,2 k €	+16.8%	298,2 k €	-46.4%	555,9 k €
Operating result	-33,8 k €	+81.6%	-183,2 k €	-159%	-70,8 k €	-2940%	2,5 k €	-86.8%	18,8 k €	-96.5%	533,8 k €	+1628%	30,9 k €	-96.3%	837,7 k €	+4788%	17,1 k €	-62.9%	46,3 k €	+78.3%	25,9 k €	-65.4%	75,1 k €	-28.1%	104,4 k €	-68.0%	326 k €	+24.6%	261,6 k €	-12.6%	299,4 k €	+28.3%	233,4 k €	-50.9%	475,5 k €
Net result	-28,2 k €	+84.5%	-181,9 k €	-160%	-70 k €	-437%	20,8 k €	+116%	9,6 k €	-97.5%	385,4 k €	+2985%	12,5 k €	-97.5%	499,4 k €	+1446%	32,3 k €	-14.0%	37,6 k €	+148%	15,2 k €	-75.8%	62,6 k €	-57.6%	147,8 k €	-49.0%	289,8 k €	+21.8%	237,8 k €	-9.9%	263,8 k €	+31.3%	201 k €	-52.9%	427 k €
Balance sheet
Equity	2,5 M €	-1.1%	2,5 M €	-6.8%	2,7 M €	-2.5%	2,8 M €	+0.8%	2,7 M €	-0.9%	2,8 M €	+16.1%	2,4 M €	+0.5%	2,4 M €	+26.7%	1,9 M €	+1.8%	1,8 M €	+2.1%	1,8 M €	+0.9%	1,8 M €	+3.6%	1,7 M €	+2.9%	1,7 M €	+7.0%	1,6 M €	+6.0%	1,5 M €	+8.4%	1,4 M €	+9.3%	1,2 M €
Total assets	4,1 M €	-2.2%	4,1 M €	+1.9%	4,1 M €	+11.9%	3,6 M €	+9.6%	3,3 M €	-2.0%	3,4 M €	+18.5%	2,9 M €	-1.1%	2,9 M €	+14.0%	2,5 M €	+13.9%	2,2 M €	+3.5%	2,1 M €	-3.0%	2,2 M €	+3.4%	2,1 M €	-6.2%	2,3 M €	-0.1%	2,3 M €	+4.3%	2,2 M €	-4.9%	2,3 M €	-0.8%	2,3 M €
Cash	114,5 k €	+61.7%	70,8 k €	-12.5%	80,9 k €	-50.0%	161,9 k €	-62.0%	425,5 k €	+18.8%	358,2 k €	+85.2%	193,4 k €	-19.8%	241,1 k €	+110%	115 k €	+22.9%	93,6 k €	+16.4%	80,4 k €	-52.4%	168,8 k €	-31.3%	245,8 k €	+41.9%	173,3 k €	-34.9%	266,2 k €	-19.2%	329,6 k €	-36.2%	516,4 k €	-15.4%	610,3 k €
Debts	1,3 M €	-3.7%	1,4 M €	+24.1%	1,1 M €	+85.6%	605,8 k €	+155%	237,9 k €	-10.6%	266,1 k €	+17.3%	226,8 k €	-12.6%	259,6 k €	-60.8%	661,9 k €	+72.1%	384,7 k €	+10.9%	346,9 k €	-18.9%	427,7 k €	+2.2%	418,4 k €	-31.0%	606,6 k €	-15.6%	718,3 k €	+0.7%	713,1 k €	-24.1%	939,5 k €	-12.4%	1,1 M €
Other
Workforce	0,0 ETP		0,0 ETP		0,0 ETP		–		0,3 ETP	-40.0%	0,5 ETP	-16.7%	0,6 ETP	0.0%	0,6 ETP	-25.0%	0,8 ETP	-20.0%	1,0 ETP	+11.1%	0,9 ETP	+800%	0,1 ETP	-96.9%	3,2 ETP	-57.9%	7,6 ETP	-11.6%	8,6 ETP	0.0%	8,6 ETP	-1.1%	8,7 ETP	-12.1%	9,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 19 ended

Active mandates

Anne Leenesonne

Director · since 21 décembre 2017 · until 12 décembre 2029

Active

APOCHEM

Director · since 21 décembre 2017 · until 12 décembre 2029 · 0479.416.560

Represented by Jan Cordonnier

Active

Ended mandates

Anne Leenesonne

Director · since 17 novembre 2023 · until 19 décembre 2029

Ended

APOCHEM

Director · since 17 novembre 2023 · until 19 décembre 2029 · 0479.416.560

Represented by Cordonnier JAN

Ended

Anne Leenesonne

Director · since 21 décembre 2017 · until 19 décembre 2029

Ended

Anne LEENESONNE

Director · since 21 décembre 2017 · until 20 décembre 2023

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/01/2026	27/01/2025	30/01/2024	31/01/2023	27/01/2022	26/01/2021
General meeting	17/12/2025	18/12/2024	20/12/2023	21/12/2022	15/12/2021	16/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	17/12/2025	26/01/2026	Dutch	PDF
Abridged model	30/06/2024	18/12/2024	27/01/2025	Dutch	PDF
Abridged model	30/06/2023	20/12/2023	30/01/2024	Dutch	PDF
Abridged model	30/06/2022	21/12/2022	31/01/2023	Dutch	PDF
Abridged model	30/06/2021	15/12/2021	27/01/2022	Dutch	PDF
Abridged model	30/06/2020	16/12/2020	26/01/2021	Dutch	PDF
Abridged model	30/06/2019	08/01/2020	31/01/2020	Dutch	PDF
Abridged model	30/06/2018	19/12/2018	28/01/2019	Dutch	PDF
Abridged model	30/06/2017	20/12/2017	25/01/2018	Dutch	PDF
Abridged model	30/06/2016	21/12/2016	13/01/2017	Dutch	PDF
Abridged model	30/06/2015	16/12/2015	15/01/2016	Dutch	PDF
Abridged model	30/06/2014	17/12/2014	15/01/2015	Dutch	PDF
Abridged model	30/06/2013	27/11/2013	14/02/2014	Dutch	PDF
Abridged model	30/06/2012	19/12/2012	14/02/2013	Dutch	PDF
Abridged model	30/06/2011	21/12/2011	15/02/2012	Dutch	PDF
Abridged model	30/06/2010	15/12/2010	31/01/2011	Dutch	PDF
Abridged model	30/06/2009	16/12/2009	31/01/2010	Dutch	PDF
Abridged model	30/06/2008	17/12/2008	30/01/2009	Dutch	PDF
Abridged model	30/06/2007	19/12/2007	30/01/2008	Dutch	PDF
Abridged model	30/06/2006	20/12/2006	30/01/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 19 ended

Active mandates

Anne Leenesonne

Director · since 21 décembre 2017 · until 12 décembre 2029

Active

APOCHEM

Director · since 21 décembre 2017 · until 12 décembre 2029 · 0479.416.560

Represented by Jan Cordonnier

Active

Ended mandates

Anne Leenesonne

Director · since 17 novembre 2023 · until 19 décembre 2029

Ended

APOCHEM

Director · since 17 novembre 2023 · until 19 décembre 2029 · 0479.416.560

Represented by Cordonnier JAN

Ended

Anne Leenesonne

Director · since 21 décembre 2017 · until 19 décembre 2029

Ended

Anne LEENESONNE

Director · since 21 décembre 2017 · until 20 décembre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Registered office06/09/2019
MAATSCHAPPELIJKE ZETEL
PDF
Mandates09/02/2018
ONTSLAGEN - BENOEMINGEN
PDF
Other17/05/2017
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other19/04/2013
DOEL
PDF
Mandates31/01/2012
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares17/01/2012
KAPITAAL - AANDELEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-28,2 k €↑
2024
Annual accounts 2024-181,9 k €↓
2023
Annual accounts 2023-70 k €↓
2022
Annual accounts 202220,8 k €↑
2020
Annual accounts 20209,6 k €↓
2019
Annual accounts 2019385,4 k €↑
2018
Annual accounts 201812,5 k €↓
2017
Annual accounts 2017499,4 k €↑
2016
Annual accounts 201632,3 k €↓
2015
Annual accounts 201537,6 k €↑
2014
Annual accounts 201415,2 k €↓
2013
Annual accounts 201362,6 k €↓
2012
Annual accounts 2012147,8 k €↓
2011
Annual accounts 2011289,8 k €↑
2010
Annual accounts 2010237,8 k €↓
2009
Annual accounts 2009263,8 k €↑
2008
Annual accounts 2008201 k €↓
2007
Annual accounts 2007427 k €
20/11/1987
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Labotoxico

Overview

What does Labotoxico do?

Trend over 18 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline